Lupin informs about outcome of board meeting

03 Jun 2021 Evaluate

Lupin has informed that the Board of Directors has approved the Company’s entry into the digital healthcare space with a focus to provide a digital therapeutics platform for doctors and patients in India. The Company recently incorporated a new entity in the name of Lupin Digital Health, as a wholly owned subsidiary, which will undertake this.

The above information is a part of company’s filings submitted to BSE.


Lupin Share Price

2151.05 19.25 (0.90%)
30-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.00
Dr. Reddys Lab 1218.40
Cipla 1323.95
Zydus Lifesciences 885.20
Lupin 2151.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×